381 results on '"Takamura, Masaaki"'
Search Results
2. Combination therapy of Juzentaihoto and mesenchymal stem cells attenuates liver damage and regresses fibrosis in mice
3. Relationship between detection of hepatitis B virus in saliva and periodontal disease in hepatitis B virus carriers in Japan
4. Paris II and Rotterdam criteria are the best predictors of outcomes in patients with primary biliary cholangitis in Japan
5. Microbiome in Liver Cirrhosis
6. Development of a non-alcoholic steatohepatitis model with rapid accumulation of fibrosis, and its treatment using mesenchymal stem cells and their small extracellular vesicles
7. Monitoring chronological change by liver-to-spleen attenuation ratio for secondary hepatic steatosis for a short term
8. Synthesized HMGB1 peptide attenuates liver inflammation and suppresses fibrosis in mice
9. Small extracellular vesicles derived from interferon-γ pre-conditioned mesenchymal stromal cells effectively treat liver fibrosis
10. Adipose most abundant 2 protein is a predictive marker for cisplatin sensitivity in cancers
11. Mesenchymal stem cells cultured under hypoxic conditions had a greater therapeutic effect on mice with liver cirrhosis compared to those cultured under normal oxygen conditions
12. Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases
13. Prognostic value of serum ALP levels during additional treatment in Japanese patients with primary biliary cholangitis treated with ursodeoxycholic acid and bezafibrate
14. Intra-Abdominal Hypertension and Abdominal Compartment Syndrome in Liver Diseases
15. A case report of psychiatric symptoms following direct-acting antiviral and ribavirin combination therapy for chronic hepatitis C in a patient with innate anxiety
16. Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient
17. The Visceral-to-subcutaneous Adipose Tissue Area Ratio Is Associated with Retreatment in Chronic Pancreatitis Patients with Pancreatolithiasis after Extracorporeal Shock Wave Lithotripsy
18. Possible involvement of chemokine C‐C receptor 7−programmed cell death‐1+ follicular helper T‐cell subset in the pathogenesis of autoimmune hepatitis
19. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies
20. Cumulative risk of developing a new symptom in patients with primary biliary cholangitis and its impact on prognosis
21. Formula to Predict Platelet Count after Partial Splenic Arterial Embolization in Patients with Hypersplenism
22. Blockade of ataxia telangiectasia mutated sensitizes hepatoma cell lines to sorafenib by interfering with Akt signaling
23. Involvement of DNA Damage Response via the Ccndbp1–Atm–Chk2 Pathway in Mice with Dextran-Sodium-Sulfate-Induced Colitis
24. A New Era of Treatment for Chronic Liver Disease : Viral Hepatitis and Cirrhosis
25. Hydrogen-producing small intestinal bacterial overgrowth is associated with hepatic encephalopathy and liver function
26. Longitudinal increase in albumin–bilirubin score is associated with non-malignancy-related mortality and quality of life in patients with liver cirrhosis
27. Value of shear wave velocity measurements for the risk assessment of hepatocellular carcinoma development in patients with nonalcoholic fatty liver disease: HCC risk assessment by VTTQ
28. Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case–control study
29. Liver cirrhosis with ruptured splenic artery aneurysm leading to hepatitis C treatment: A case report
30. Adenylate cyclase-associated protein 1 overexpressed in pancreatic cancers is involved in cancer cell motility
31. Clinical significance of cell cycle inhibitors in hepatocellular carcinoma
32. Involvement of liver-intestine cadherin in cancer progression
33. [Retracted] Alteration of p53-binding protein 1 expression as a risk factor for local recurrence in patients undergoing resection for extrahepatic cholangiocarcinoma
34. Additional file 1 of Synthesized HMGB1 peptide attenuates liver inflammation and suppresses fibrosis in mice
35. Increased Susceptibility to Severe Chronic Liver Damage in CXCR4 Conditional Knock-Out Mice
36. Grafting and crosslinking reaction of carboxyl-terminated liquid rubber with silica nanoparticles and carbon black in the presence of Sc(OTf) 3
37. Increase of fucosylated alpha-fetoprotein fraction at the onset of autoimmune hepatitis and acute liver failure
38. Novel Strategy for Diagnosis of Focal Nodular Hyperplasia Using Gadolinium Ethoxybenzyl Diethylenetriaminepentaacetic Acid: Enhanced Magnetic Resonance Imaging and Magnetic Resonance Elastography
39. Tumor suppressor carcinoembryonic antigen-related cell adhesion molecule 1 potentates the anchorage-independent growth of human hepatoma HepG2 cells
40. An inhibitor of c- Jun NH2-terminal kinase, SP600125, protects mice from d-galactosamine/lipopolysaccharide-induced hepatic failure by modulating BH3-only proteins
41. Detection of Fibrous Liver Under Congestion by a Gravity-assisted Evaluation of Liver Stiffness
42. Molecular Mechanisms and Treatment of Sarcopenia in Liver Disease: A Review of Current Knowledge
43. Recurrence of hepatocellular carcinoma 102 months after successful eradication and removal of membranous obstruction of the inferior vena cava
44. WED-293 - Prognostic value of serum ALP levels during additional treatment in Japanese patients with primary biliary cholangitis treated with ursodeoxycholic acid and bezafibrate
45. p21-activated kinase-2 is a critical mediator of transforming growth factor-β-induced hepatoma cell migration
46. MEK/ERK signaling is a critical mediator for integrin-induced cell scattering in highly metastatic hepatocellular carcinoma cells
47. Presence of antibodies against self-HLA class II molecules in autoimmune hepatitis: 1712
48. Obesity and accumulation of subcutaneous adipose tissue are poor prognostic factors in patients with alcoholic liver cirrhosis
49. Blocking sphingosine 1-phosphate receptor 2 accelerates hepatocellular carcinoma progression in a mouse model of NASH
50. Screening and follow‐up of chronic liver diseases with understanding their etiology in clinics and hospitals
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.